Lab Med Online.  2020 Jul;10(3):185-196. 10.3343/lmo.2020.10.3.185.

Recommendations for Liquid Chromatography-Mass Spectrometry in the Clinical Laboratory: Part III. Quality Assurance

• Kim S
• Lee SG
• Moon SY
• Park HD
• Song SH
• Lee K
• Choi HJ
• Lee SY
• Clinical Mass Spectrometry Research Committee of the Korean Society of Clinical Chemistry

• KMID: 2504127
• DOI: http://doi.org/10.3343/lmo.2020.10.3.185

Abstract

The use of liquid chromatography-tandem mass spectrometry (LC-MS/MS) in clinical laboratories is increasing and is likely to expand into even more clinical venues in the future. Mass spectrometry is the standard method for analyte identification in the clinical chemistry field; however, differences in mass spectrometry protocols and handling affect the accuracy and reliability of these tests and prevent direct comparisons of results between laboratories. For example, the results of laboratories using LC-MS/MS methods are less likely to be reproducible than those of laboratories using conventional, automated methods. This is due to inadequate handling of the equipment and/or poor quality control after the implementation of the method, which may result in unnecessary medical expenditures or even adverse outcomes for the patients. Unfortunately, guidelines to monitor the accuracy of LC-MS/MS-based clinical tests are still lacking. In general, the quality control methods used in conventional clinical tests could also be applied to LC-MS/MS. However, additional quality control methods specific to LC-MS/MS techniques must be continuously employed to maintain the same quality level achieved during method development and verification. This report is intended to help clinical laboratories that operate LC-MS/MS improve the accuracy and reliability of their testing by providing guidance for quality assurance and improvement, based on a collection of existing guidelines and expert opinions from the literature.

Keyword

Liquid chromatography-tandem mass spectrometry; Recommendation; Clinical testing; Quality assurance; Quality control; Post-implementation monitoring; Clinical laboratories

Reference

1. International Organization for Standardization (ISO). 2015. Quality management systems - Fundamentals and vocabulary. ISO 9000. ISO/TC 176/SC 1: International Organization for Standardization.

2. Lynch KL. LC-MS/MS quality assurance in production. American Association for Clinical Chemistry. Clinical Laboratory News. https://www.aacc.org/publications/cln/articles/2017/may/mass-spectrometry-quality-assurance-in-production-the-real-work-begins-after-validation. Updated on May 2017.

3. Rifai N, Horvath AR, editors. 2018. Tietz textbook of clinical chemistry and molecular diagnostics. 6th ed. Elsevier;St. Louis, MO: p. 266–326.

4. Clinical and Laboratory Standards Institute. 2016; Statistical quality control for quantitative measurement procedures: Principles and definitions; Approved guideline-4th edition. CLSI guideline C24-A4. Clinical and Laboratory Standards Institute;Wayne, PA:

5. U.S. Department of Health and Human Services Food and Drug Administrations. Bioanalytical method validation; Guidance for industry. Docket No. FDA-2013-D-1020. Silver Spring, MD: Center for Drug Evaluation and Research, Food and Drug Administrations, 2013. https://www.fda.gov/files/drugs/published/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf. Updated on May 2018.

6. Clinical and Laboratory Standards Institute. 2014; Liquid chromatography-mass spectrometry methods; Approved guideline. CLSI guideline C62-A. Clinical and Laboratory Standards Institute;Wayne, PA:

7. Briscoe CJ, Stiles MR, Hage DS. 2007; System suitability in bioanalytical LC/MS/MS. J Pharm Biomed Anal. 44:484–91. DOI: 10.1016/j.jpba.2007.03.003. PMID: 17433601.

8. Clinical and Laboratory Standards Institute. 2007; Mass spectrometry in the clinical laboratory: General principles and guidance, Approved guideline. CLSI guideline C50-A. Clinical and Laboratory Standards Institute;Wayne, PA:

9. Clinical and Laboratory Standards Institute. 2017; Newborn screening by tandem mass spectrometry, Approved guideline-2nd edition. CLSI gui-deline NBS04. Clinical and Laboratory Standards Institute;Wayne, PA:

10. The College of American Pathologists. Accreditation program check¬lists-2019 edition. https://documents.cap.org/documents/2019-CAP-accreditation-checklist-summary.pdf The College of American Pathologists, 2019. Updated on Sep. 2019.

11. Laboratory Medicine Foundation (LMF). 2019. Accreditation program checklists; clinical chemistry. Laboratory Medicine Foundation.

12. Garofolo F. Chan CC, Lam H, editors. 2004. LC-MS instrument calibration. Analytical method validation and instrument performance verification. John Wiley & Sons;Hoboken, NJ: p. 197–220. DOI: 10.1002/0471463728.ch13.

13. Clinical and Laboratory Standards Institute. 2003; Evaluation of the linearity of quantitative measurement procedures: A statistical approach, approved guideline. CLSI docment EP06-A. Clinical and Laboratory Standards Institute;Wayne, PA:

14. Clinical and Laboratory Standards Institute. 2013; User evaluation of between-reagent lot variation, Approved guideline. CLSI document EP26-A. Clinical and Laboratory Standards Institute;Wayne, PA:

15. Clinical and Laboratory Standards Institute. 2018; Measurement procedure comparison and bias estimation using patient samples, Approved guideline-3rd edition. CLSI guideline EP09c. Clinical and Laboratory Standards Institute;Wayne, PA:

16. Ministry of Food and Drug Safety. 2013. Guideline on bioanalytical method validation. Administrative publication 11-1471000-000028-01. Ministry of Food and Drug Safety;Choengju: http://www.nifds.go.kr/brd/m_15/down.do?.brd_id=167&seq=7018&data_tp=A&file_seq=1. Updated by Dec. 2013.

17. European Medicines Agency. Guideline on bioanalytical method validation. EMEA/CHMP/EWP/192217/2009 Rev. 1 Corr. 2**. Committee for Medicinal Products for Human Use, European Medicines Agency;London: https://www.ema.europa.eu/en/documents/scientic-guideline/guideline-bioanalytical-method-validation_en.pdf. Updated on Jun. 2015.

18. Clinical and Laboratory Standards Institute. 2012; Verification of comparability of patient results within one health care system, Approved guideline (interim revision). CLSI document EP31-A-IR. Clinical and Laboratory Standards Institute;Wayne, PA:

19. Clinical and Laboratory Standards Institute. 2016; Using proficiency testing and alternative assessment to improve medical laboratory quality, Approved guideline-3rd edition. CLSI guideline QMS24. Clinical and Laboratory Standards Institute;Wayne, PA: